{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:16:13Z","timestamp":1760782573743},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Gen Intern Med"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1111\/j.1525-1497.2004.30280.x","type":"journal-article","created":{"date-parts":[[2004,4,2]],"date-time":"2004-04-02T15:21:34Z","timestamp":1080919294000},"page":"302-309","source":"Crossref","is-referenced-by-count":22,"title":["Do physicians tailor their recommendations for breast cancer risk reduction based on patient\u2019s risk?"],"prefix":"10.1007","volume":"19","author":[{"given":"Jennifer S.","family":"Haas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Celia P.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven E.","family":"Gregorich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliseo J.","family":"P\u00e9rez-Stable","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve Des","family":"Jarlais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"1904302_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3322\/canjclin.47.1.5","volume":"47","author":"SL Parker","year":"1997","unstructured":"Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics, 1997. CA Cancer J Clin. 1997;47:5\u201327.","journal-title":"CA Cancer J Clin"},{"key":"1904302_CR2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66\u201371.","journal-title":"Science"},{"key":"1904302_CR3","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1093\/jnci\/90.18.1371","volume":"90","author":"B Fisher","year":"1998","unstructured":"Fisher B, Costantino JP, Wickerham DL, et al. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 1998;90:1371\u201388.","journal-title":"J Natl Cancer Inst"},{"key":"1904302_CR4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199901143400201","volume":"340","author":"LC Hartmann","year":"1999","unstructured":"Hartmann LC, Schaid DJ, Woods JE, et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. N Engl J Med. 1999;340:77\u201384.","journal-title":"N Engl J Med"},{"key":"1904302_CR5","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1093\/jnci\/93.21.1633","volume":"93","author":"LC Hartmann","year":"2001","unstructured":"Hartmann LC, Sellers TA, Schaid DJ, et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. J Natl Cancer Inst. 2001;93:1633\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"1904302_CR6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(98)05071-5","volume":"352","author":"T Powles","year":"1998","unstructured":"Powles T, Eeles R, Ashley S, et al. Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomized chemoprevention trial. Lancet. 1998;352:98\u2013101.","journal-title":"Lancet"},{"key":"1904302_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(98)85011-3","volume":"352","author":"U Veronesi","year":"1998","unstructured":"Veronesi U, Maisonneuve P, Costa A, et al. Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomized trial among hysterectomized women. Italian Tamoxifen Prevention Study. Lancet. 1998;352:93\u20137.","journal-title":"Lancet"},{"key":"1904302_CR8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/jncimono\/1997.22.27","volume":"22","author":"S Shapiro","year":"1997","unstructured":"Shapiro S. Periodic screening for breast cancer: the HIP Randomized Controlled Trial. Health Insurance Plan. J Natl CAncer Inst. 1997;22:27\u201330.","journal-title":"J Natl CAncer Inst"},{"key":"1904302_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jncimono\/1997.22.43","volume":"22","author":"L Tabar","year":"1997","unstructured":"Tabar L, Chen HH, Fagerberg G, Duffy SW, Smith TC. Recent results from the Swedish Two-County Trial. The effects of age, histologic type, and mode of detection on the efficacy of breast cancer screening. J Natl Cancer Inst. 1997;22:43\u20137.","journal-title":"J Natl Cancer Inst"},{"key":"1904302_CR10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/jncimono\/1997.22.5","volume":"22","author":"SW Fletcher","year":"1997","unstructured":"Fletcher SW. Breast cancer screening among women in their forties: an overview of the issues. J Natl Cancer Inst. 1997;22:5\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"1904302_CR11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/jncimono\/1997.22.79","volume":"22","author":"K Kerlikowske","year":"1997","unstructured":"Kerlikowske K. Efficacy of screening mammography among women aged 40\u201349 years and 50\u201369 years. Comparison of relative and absolute benefit. J Natl Cancer Inst. 1997;22:79\u201386.","journal-title":"J Natl Cancer Inst"},{"key":"1904302_CR12","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJMcp021804","volume":"348","author":"SW Fletcher","year":"2003","unstructured":"Fletcher SW, Elmore JG. Clinical practice. Mammographic screening for breast cancer. N Engl J Med. 2003;348:1672\u201380.","journal-title":"N Engl J Med"},{"key":"1904302_CR13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/jnci\/90.5.389","volume":"90","author":"M Mezetti","year":"1998","unstructured":"Mezetti M, La Vecchia C, Decarli A, Boyle P, Talamini R, Franceschi S. Population attributable risk for breast cancer: diet, nutrition and physical exercise. J Natl Cancer Inst. 1998;90:389\u201393.","journal-title":"J Natl Cancer Inst"},{"key":"1904302_CR14","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/oxfordjournals.aje.a009447","volume":"147","author":"MD Gammon","year":"1998","unstructured":"Gammon MD, Schoenberg JB, Britton JA, et al. Recreational physical activity and breast cancer risk among women under age 45 years. Am J Epidemiol. 1998;147:273\u201380.","journal-title":"Am J Epidemiol"},{"key":"1904302_CR15","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/jama.1997.03550170037029","volume":"278","author":"Z Huang","year":"1997","unstructured":"Huang Z, Hankinson SE, Colditz GA, et al. Dual effects of weight and weight gain on breast cancer risk. JAMA. 1997;278:1407\u201311.","journal-title":"JAMA"},{"key":"1904302_CR16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1001\/jama.279.7.535","volume":"279","author":"S Smith-Warner","year":"1998","unstructured":"Smith-Warner S, Spiegelman D, Yaun S-S, et al. Alcohol and breast cancer in women. A pooled analysis of cohort studies. JAMA. 1998;279:535\u20139.","journal-title":"JAMA"},{"key":"1904302_CR17","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMe020152","volume":"347","author":"A Kallioniemi","year":"2002","unstructured":"Kallioniemi A. Molecular signatures of breast cancer\u2014predicting the future. N Engl J Med. 2002;347:2067\u20138.","journal-title":"N Engl J Med"},{"key":"1904302_CR18","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1093\/jnci\/81.24.1879","volume":"81","author":"MH Gail","year":"1989","unstructured":"Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879\u201386.","journal-title":"J Natl Cancer Inst"},{"key":"1904302_CR19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11606-006-0005-3","volume":"12","author":"N Lurie","year":"1997","unstructured":"Lurie N, Margolis KL, Mink PJ, Slater JS. Why do patients of female physicians have higher rate of breast and cervical cancer screening? J Gen Intern Med. 1997;12:34\u201343.","journal-title":"J Gen Intern Med"},{"key":"1904302_CR20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/00007611-199606000-00006","volume":"89","author":"CJ Herman","year":"1996","unstructured":"Herman CJ, Lengerich EJ, Stood G. Variation in recommendations for breast and cervical cancer screening among primary care physicians in North Carolina. South Med J. 1996;89:583\u201390.","journal-title":"South Med J"},{"key":"1904302_CR21","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1748-0361.1997.tb00940.x","volume":"13","author":"HL Howe","year":"1997","unstructured":"Howe HL, Katterhagen JG. Effects of physician outreach programs on rural-urban differences in breast cancer management. J Rural Health. 1997;13:109\u201317.","journal-title":"J Rural Health"},{"key":"1904302_CR22","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1056\/NEJM199204233261702","volume":"326","author":"AB Nattinger","year":"1992","unstructured":"Nattinger AB, Gottlieb MS, Veum J, Yahnke D, Goodwin JS. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992;326:1102\u20137.","journal-title":"N Engl J Med"},{"key":"1904302_CR23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jama.1996.03530360023033","volume":"275","author":"VL Ernster","year":"1996","unstructured":"Ernster VL, Barclay J, Kerlikowske K, Grady D, Henderson C. Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA. 1996;275:913\u20138.","journal-title":"JAMA"},{"key":"1904302_CR24","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3322\/canjclin.52.5.256","volume":"52","author":"M Morrow","year":"2002","unstructured":"Morrow M, Strom EA, Bassett LW, et al. Standard for the management of ductal carcinoma in situ of the breast (DCIS). CA Cancer J Clin. 2002;52:256\u201376.","journal-title":"CA Cancer J Clin"},{"key":"1904302_CR25","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1093\/jnci\/djg097","volume":"95","author":"K Kerlikowske","year":"2003","unstructured":"Kerlikowske K, Molinaro A, Cha I, et al. Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy. J Natl Cancer Inst. 2003;95:1692\u2013702.","journal-title":"J Natl Cancer Inst"},{"key":"1904302_CR26","doi-asserted-by":"crossref","first-page":"270","DOI":"10.2307\/2533218","volume":"50","author":"SR Lipsitz","year":"1994","unstructured":"Lipsitz SR, Fitzmaurice GM, Orav EJ, Laird NM. Performance of generalized estimating equations in practical situations. Biometrics. 1994;50:270\u20138.","journal-title":"Biometrics"},{"key":"1904302_CR27","unstructured":"U.S. Preventive Services Task Force. 2002. Available at: http:\/\/www.ahcpr.gov\/clinic\/uspstfix.htm. Accessed February 27, 2004."},{"key":"1904302_CR28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.1995.03520260071035","volume":"273","author":"K Kerlikowske","year":"1995","unstructured":"Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography. A meta-analysis. JAMA. 1995;273:149\u201354.","journal-title":"JAMA"},{"key":"1904302_CR29","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/oxfordjournals.aje.a114156","volume":"122","author":"WC Willet","year":"1985","unstructured":"Willet WC, Browne ML, Bain C. Relative weight and risk of breast cancer among premenopausal women. Am J Epidemiol. 1985;122:731\u20139.","journal-title":"Am J Epidemiol"},{"key":"1904302_CR30","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF00115638","volume":"7","author":"DJ Hunter","year":"1996","unstructured":"Hunter DJ, Willett WC. Nutrition and breast cancer. Cancer Causes Control. 1996;7:56\u201368.","journal-title":"Cancer Causes Control"},{"key":"1904302_CR31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1093\/oxfordjournals.aje.a116268","volume":"135","author":"DR Pathak","year":"1992","unstructured":"Pathak DR, Whittemore AS. Combined effects of body size, parity and menstrual events on breast cancer incidence in seven countries. Am J Epidemiol. 1992;135:153\u201367.","journal-title":"Am J Epidemiol"},{"key":"1904302_CR32","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1093\/jnci\/87.17.1297","volume":"87","author":"SE Hankinson","year":"1995","unstructured":"Hankinson SE, Willet WC, Manson JE. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. J Natl Cancer Inst. 1995;87:1297\u2013302.","journal-title":"J Natl Cancer Inst"},{"key":"1904302_CR33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0305-7372(02)00107-X","volume":"29","author":"GH Sakorafas","year":"2003","unstructured":"Sakorafas GH. The management of women at high risk for the development of breast cancer: risk estimation and preventative strategies. Cancer Treat Rev. 2003;29:79\u201389.","journal-title":"Cancer Treat Rev"},{"key":"1904302_CR34","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/jnci\/94.20.1546","volume":"94","author":"VL Ernster","year":"2002","unstructured":"Ernster VL, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst. 2002;94:1546\u201354.","journal-title":"J Natl Cancer Inst"},{"key":"1904302_CR35","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1001\/archinte.160.7.953","volume":"160","author":"VL Ernster","year":"2000","unstructured":"Ernster VL, Barclay J, Kerlikowske K, Wilkie H, Ballard-Barbash R. Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program. Arch Intern Med. 2000;160:953\u20138.","journal-title":"Arch Intern Med"},{"key":"1904302_CR36","first-page":"295","volume":"12","author":"L Wideroff","year":"2003","unstructured":"Wideroff L, Freedman AN, Olson L, et al. Physician use of genetic testing for cancer susceptibility: results of a national survey. Cancer Epidemiol Biomarkers Prev. 2003;12:295\u2013303.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1904302_CR37","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(02)09962-2","volume":"360","author":"J Cuzick","year":"2002","unstructured":"Cuzick J, Forbes J, Edwards R, et al. First results from the International Breast Cancer Intervention Study (IBIS-I): a randomized prevention trial. Lancet. 2002;360:817\u201324.","journal-title":"Lancet"},{"key":"1904302_CR38","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/jnci\/95.7.526","volume":"95","author":"AN Freedman","year":"2003","unstructured":"Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH. Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention. J Natl Cancer Inst. 2003;95:526\u201332.","journal-title":"J Natl Cancer Inst"},{"key":"1904302_CR39","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJM199705153362022","volume":"336","author":"D Schrag","year":"1997","unstructured":"Schrag D, Kuntz KM, Garber JE, Weeks JC. Decision analysis\u2014effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med. 1997;336:1465\u201371.","journal-title":"N Engl J Med"},{"key":"1904302_CR40","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1006\/pmed.1998.0349","volume":"27","author":"AY Kinney","year":"1998","unstructured":"Kinney AY, Richards C, Vernon SW, Vogel VG. The effect of physician recommendation on enrollment in the breast cancer chemoprevention trial. Prev Med. 1998;27(5 Part 1):713\u20139.","journal-title":"Prev Med"},{"key":"1904302_CR41","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1001\/archinte.1994.00420180062008","volume":"154","author":"SA Fox","year":"1994","unstructured":"Fox SA, Siu AL, Stein JA. The importance of physician communication on breast cancer screening of older women. Arch Intern Med. 1994;154:2058\u201368.","journal-title":"Arch Intern Med"},{"key":"1904302_CR42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1089\/10906570260199366","volume":"6","author":"K Armstrong","year":"2002","unstructured":"Armstrong K, Stopfer J, Calzone K, Fitzgerald G, Coyne J, Weber B. What does my doctor think? Preferences for knowing the doctor\u2019s opinion among women considering clinical testing for BRCA1\/2 mutations. Genet Test. 2002;6:115\u20138.","journal-title":"Genet Test"},{"key":"1904302_CR43","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2105\/AJPH.93.4.635","volume":"93","author":"KS Yarnall","year":"2003","unstructured":"Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL. Primary care: is there enough time for prevention? Am J Public Health. 2003;93:635\u201341.","journal-title":"Am J Public Health"},{"key":"1904302_CR44","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2105\/AJPH.85.6.801","volume":"85","author":"F Houn","year":"1995","unstructured":"Houn F, Helzlsouer KJ, Friedmna NB, Stefanek ME. The practice of prophylactic mastectomy. A survey of Maryland surgeons. Am J Public Health. 1995;85:801\u20135.","journal-title":"Am J Public Health"},{"key":"1904302_CR45","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0029-7844(99)00425-1","volume":"94","author":"E Frank","year":"1999","unstructured":"Frank E, Rock J, Sara D. Characteristics of female obstetrician-gynecologists in the United States. Obstet Gynecol. 1999;94(5 Part 1):659\u201365.","journal-title":"Obstet Gynecol"},{"key":"1904302_CR46","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00005650-200202000-00010","volume":"40","author":"TK Gandhi","year":"2002","unstructured":"Gandhi TK, Francis EC, Puopolo AL, Burstin HR, Haas JS, Brennan TA. Inconsistent report cards: assessing the comparability of various measures of the quality of ambulatory care. Med Care. 2002;40:155\u201365.","journal-title":"Med Care"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1111\/j.1525-1497.2004.30280.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T01:39:38Z","timestamp":1524793178000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1111\/j.1525-1497.2004.30280.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":46,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["1904302"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-1497.2004.30280.x","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}